Popovits Kimberly J (CIK 1333482) reported 11 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy KARD (20,706 shares), Buy TXG (8,829 shares), Buy KNSA (2,799 shares), Sell EXAS (6,725 shares), Sell EXAS (9,656 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Kardigan, Inc. (KARD) | Director | Buy | 20,706 | $0 |
| 2026-06-08 | 10x Genomics, Inc. (TXG) | Director | Buy | 8,829 | $0 |
| 2026-06-02 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 2,799 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | Director | Sell | 6,725 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | Director | Sell | 9,656 | $0 |
| 2025-08-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 45,748 | $473,949 |
| 2025-08-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 18,760 | $290,217 |
| 2025-08-01 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Sell | 64,508 | $1.9M |
| 2025-06-16 | EXACT SCIENCES CORP (EXAS) | Director | Buy | 9,994 | $0 |
| 2025-06-05 | 10x Genomics, Inc. (TXG) | Director | Buy | 15,357 | $0 |
| 2025-06-05 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 3,173 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22